Moderna says FDA delayed RSV vaccine approval to end of May

Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to "administrative constraints" at the agency. The FDA was expected to make a decision on the RSV shot on Sunday. The agency has not informed…#fda #rsv #moderna #pfizer #gsk #cdc #stephenhoge #rna
Source: Reuters: Health - Category: Consumer Health News Source Type: news